Risk Factors for Colonization With Antibiotic-Resistant Bacteria Among Hospitalized Patients in Bangladesh: An Antibiotic Resistance in Communities and Hospitals (ARCH) Study
- 31 October 2026
- journal article
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 13 (11)
Abstract
Background: Antibiotic-resistant bacteria (ARB) are frequently linked with healthcare settings, but specific factors associated with colonization within healthcare settings in low- and middle-income countries (LMICs) remain poorly understood. This study explores risk factors for ARB colonization among hospitalized patients in Bangladesh, where 82% were colonized with extended-spectrum cephalosporin-resistant Enterobacterales (ESCrE), 37% with carbapenem-resistant Enterobacterales (CRE), and 21% with methicillin-resistant Staphylococcus aureus (MRSA). Methods: Hospitalized adults from 3 hospitals in Dhaka completed interviews and underwent chart review to assess healthcare exposures. We used bivariate analyses, random forest variable selection, and multivariate logistic regression to identify factors associated with ESCrE, CRE, and MRSA colonization. Results: ESCrE colonization was associated with admission to a non-medical ward (aOR 2.16–8.57, 95% CI 1.14, 64.4) and hospitalization ≥ 3 days before specimen collection (aOR 1.74, 95% CI 1.13, 2.69) while being inversely associated with age (≥45 years, aOR 0.54–0.58, 95% CI .29, .99) and carbapenem use (aOR 0.02, 95% CI < .01, .14). CRE colonization was associated with hospitalization ≥ 3 days before specimen collection (aOR 1.56, 95% CI 1.08, 2.23), third-generation cephalosporin use (aOR 2.93, 95% CI 2.02, 4.23), and other beta-lactam use (aOR 4.83, 95% CI 2.65, 8.81). MRSA colonization was inversely associated with third-generation cephalosporin use (OR 0.60, 95% CI .38, .95). Conclusions: Antibiotic use, duration of hospitalization, age, and ward type were associated with ARB colonization among hospitalized patients. Further investigations into antibiotic use patterns and infection prevention and control practices may identify modifiable risk factors to reduce ARB in healthcare settings in LMICs.Keywords
This publication has 30 references indexed in Scilit:
- Epidemiological data on the acquisition of carbapenem-resistant Enterobacterales through weekly rectal swabs in non-critically ill patients undergoing antimicrobial therapy: a short-term surveillance studyAntimicrobial Stewardship & Healthcare Epidemiology, 2025
- Risk factors for colonisation by Multidrug-Resistant bacteria in critical care unitsIntensive and Critical Care Nursing, 2024
- Risk factors for colonization with extended-spectrum cephalosporin-resistant and carbapenem-resistant Enterobacterales among hospitalized patients in Guatemala: An Antibiotic Resistance in Communities and Hospitals (ARCH) studyIJID Regions, 2024
- Incidence of infection with multidrug-resistant Gram-negative bacteria and vancomycin-resistant enterococci in carriers: a systematic review and meta-regression analysisThe Lancet Infectious Diseases, 2023
- Whole genome sequencing reveals hidden transmission of carbapenemase-producing EnterobacteralesNature Communications, 2022
- Antibiotic-resistant organisms establish reservoirs in new hospital built environments and are related to patient blood infection isolatesCommunications Medicine, 2022
- Global burden of bacterial antimicrobial resistance in 2019: a systematic analysisThe Lancet, 2022
- Colonization resistance against multi-drug-resistant bacteria: a narrative reviewJournal of Hospital Infection, 2021
- The effect of prophylaxis with ertapenem versus cefuroxime/metronidazole on intestinal carriage of carbapenem-resistant or third-generation-cephalosporin-resistant Enterobacterales after colorectal surgeryClinical Microbiology and Infection, 2021
- Estimating the association between antibiotic exposure and colonization with extended-spectrum β-lactamase-producing Gram-negative bacteria using machine learning methods: a multicentre, prospective cohort studyClinical Microbiology and Infection, 2020